Distinct glomerular disease association after vaccination with BNT162b2 and mRNA-1273: a VigiBase analysis.
作者信息
Kronbichler Andreas, Jung Se Yong, Kim Min Seo, Shin Jae Il
机构信息
Department of Medicine, University of Cambridge, Cambridge, UK.
Department of Pediatrics, Division of Pediatric Cardiology, Yonsei University College of Medicine, Seoul, Korea.
出版信息
Kidney Int. 2022 Feb;101(2):415-416. doi: 10.1016/j.kint.2021.11.013. Epub 2021 Nov 22.
Abstract
摘要
相似文献
1
Distinct glomerular disease association after vaccination with BNT162b2 and mRNA-1273: a VigiBase analysis.接种BNT162b2和mRNA-1273疫苗后的不同肾小球疾病关联：一项VigiBase分析
Kidney Int. 2022 Feb;101(2):415-416. doi: 10.1016/j.kint.2021.11.013. Epub 2021 Nov 22.
2
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar.mRNA-1273和BNT162b2疫苗在卡塔尔的有效性。
N Engl J Med. 2022 Feb 24;386(8):799-800. doi: 10.1056/NEJMc2117933. Epub 2022 Jan 19.
3
Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.接种BNT162b2和mRNA-1273后新型冠状病毒2型抗体反应的比较
JAMA. 2021 Oct 19;326(15):1533-1535. doi: 10.1001/jama.2021.15125.
4
[Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].[BNT162b2 mRNA新冠疫苗接种后免疫性血小板减少症]
Rinsho Ketsueki. 2021;62(11):1639-1642. doi: 10.11406/rinketsu.62.1639.
5
Myocarditis after vaccination against covid-19.接种新冠疫苗后发生的心肌炎
BMJ. 2021 Dec 16;375:n3090. doi: 10.1136/bmj.n3090.
6
Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.肾移植受者中mRNA-1273和BNT162b2新冠病毒mRNA疫苗免疫原性的比较
Transpl Int. 2022 Jan 4;35:10026. doi: 10.3389/ti.2021.10026. eCollection 2021.
7
Cutaneous reactions due to Pfizer's BNT162b2 mRNA and Moderna's mRNA-1273 vaccines.辉瑞公司的BNT162b2 mRNA疫苗和莫德纳公司的mRNA-1273疫苗引起的皮肤反应。
J Eur Acad Dermatol Venereol. 2022 May;36(5):e332-e334. doi: 10.1111/jdv.17925. Epub 2022 Jan 25.
8
Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry.多国静脉血栓栓塞症注册研究中，接种 SARS-CoV-2 疫苗后 30 天内的静脉血栓栓塞症。
Viruses. 2022 Jan 18;14(2):178. doi: 10.3390/v14020178.
9
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.异源 ChAdOx1 nCoV-19 和 BNT162b2 疫苗加强接种可引发针对流行的 SARS-CoV-2 变体的强大中和抗体反应和 T 细胞反应性。
EBioMedicine. 2022 Jan;75:103761. doi: 10.1016/j.ebiom.2021.103761. Epub 2021 Dec 17.
10
Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data.mRNA-BNT162b2、mRNA-1273 和 ChAdOx1 nCoV-19 疫苗在医护人员中预防 COVID-19 的有效性：基于监测数据的观察性研究。
Clin Microbiol Infect. 2021 Nov;27(11):1699.e5-1699.e8. doi: 10.1016/j.cmi.2021.06.043. Epub 2021 Jul 13.
引用本文的文献
1
An Unusual Case of Membranoproliferative Glomerulonephritis: Is the Role of Vaccination in Immune Reactivation a Casual or Causal Effect?一例罕见的膜增生性肾小球肾炎病例：疫苗接种在免疫激活中的作用是偶然还是因果效应？
Reports (MDPI). 2025 Aug 8;8(3):141. doi: 10.3390/reports8030141.
2
C3 Glomerulonephritis Post COVID-19 Vaccination: A Case Report and Review of the Literature.新冠疫苗接种后C3肾小球肾炎：一例病例报告及文献综述
Brown J Hosp Med. 2022 Aug 1;1(3):37264. doi: 10.56305/001c.37264. eCollection 2022.
3
Assessing acute kidney injury risk after COVID vaccination and infection in a large cohort study.在一项大型队列研究中评估新冠疫苗接种和感染后的急性肾损伤风险。
NPJ Vaccines. 2024 Nov 8;9(1):213. doi: 10.1038/s41541-024-00964-3.
4
[Diagnosis and therapy of granulomatosis with polyangiitis and microscopic polyangiitis-2023: consensus of the Austrian society of nephrology (ÖGN) and Austrian society of rheumatology (ÖGR)].[2023年肉芽肿性多血管炎和显微镜下多血管炎的诊断与治疗：奥地利肾脏病学会（ÖGN）和奥地利风湿病学会（ÖGR）共识]
Wien Klin Wochenschr. 2023 Aug;135(Suppl 5):656-674. doi: 10.1007/s00508-023-02262-9. Epub 2023 Sep 20.
5
[Diagnosis and treatment of Minimal Change Disease in adults-2023].[成人微小病变病的诊断与治疗 - 2023]
Wien Klin Wochenschr. 2023 Aug;135(Suppl 5):628-637. doi: 10.1007/s00508-023-02258-5. Epub 2023 Sep 20.
6
Renal Complications Following COVID-19 Vaccination: A Narrative Literature Review.新冠疫苗接种后的肾脏并发症：一篇叙述性文献综述
Indian J Community Med. 2023 Mar-Apr;48(2):214-219. doi: 10.4103/ijcm.ijcm_654_22. Epub 2023 Apr 7.
7
Development of crescentic membranoproliferative glomerulonephritis after COVID-19 vaccination.新型冠状病毒肺炎疫苗接种后新月体性膜增生性肾小球肾炎的发生
Clin Kidney J. 2022 Oct 19;15(12):2340-2342. doi: 10.1093/ckj/sfac222. eCollection 2022 Dec.
8
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions.COVID-19 大流行对肾脏领域的影响：经验教训和未来方向。
Nat Rev Nephrol. 2022 Nov;18(11):724-737. doi: 10.1038/s41581-022-00618-4. Epub 2022 Aug 24.
9
Idiopathic nephrotic syndrome relapse following COVID-19 vaccination: a series of 25 cases.新冠病毒疫苗接种后特发性肾病综合征复发：25例系列病例
Clin Kidney J. 2022 May 6;15(8):1574-1582. doi: 10.1093/ckj/sfac134. eCollection 2022 Aug.
10
Current Evidence in SARS-CoV-2 mRNA Vaccines and Post-Vaccination Adverse Reports: Knowns and Unknowns.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）信使核糖核酸（mRNA）疫苗及接种后不良报告的当前证据：已知与未知
Diagnostics (Basel). 2022 Jun 26;12(7):1555. doi: 10.3390/diagnostics12071555.
Zotero 插件